Neurotransmitters and neuromodulators
Neurotransmitters and neuromodulators are chemical messengers that play essential roles in signal transmission within neural circuits. Neurotransmitters are released from the axon terminals of presynaptic neurons and rapidly excite (e.g., glutamate) or inhibit (e.g., γ-aminobutyric acid, GABA) postsynaptic neurons on a sub-second timescale. They are stored in synaptic vesicles and released into the synaptic cleft in response to action potentials. In contrast, neuromodulators are diffusible signaling molecules that regulate the activity of populations of neurons and operate over both fast and slow timescales. Importantly, even classical fast neurotransmitters such as glutamate do not always function exclusively through point-to-point synaptic transmission. Neurotransmitters can diffuse from the synaptic cleft into the extracellular space and activate extrasynaptic receptors at considerable distances, a process known as volumetric transmission.
Neurotransmitters and neuromodulators are fundamental to cognition and behavior. The relationship between chemical signaling in the brain and complex animal behavior can now be investigated using modern fluorescent biosensors, which provide high spatiotemporal resolution for visualizing rapid neurotransmitter dynamics within neural circuits of behaving animals.
Fluorescent proteins
Fluorescent proteins (FPs) are fundamental components of modern biosensors. Two principal strategies are used to incorporate FPs into biosensor designs. The first relies on Förster resonance energy transfer (FRET) between two FPs. In FRET-based sensors, excitation of a donor FP leads to non-radiative transfer of energy to a nearby acceptor chromophore, producing a measurable fluorescence change. The second strategy uses circularly permuted fluorescent proteins (cpFPs) , in which the original protein sequence is rearranged while preserving the overall fold. Specific regions of cpFPs tolerate insertion of sensing domains, and conformational changes in these inserts can strongly modulate fluorescence intensity. Circular permutation also alters the orientation of the chromophore relative to fusion partners, a property that can be exploited to optimize FRET-based biosensors by incorporating cpFPs. Fluorescent biosensors can be delivered to the brain using viral vectors, such as AAV and monitored in behaving animals with a range of optical techniques, including fiber photometry and multichannel fiber photometry, stationary two-photon (2P) microscopy, and miniaturized head-mounted microscopes. Neurotransmitter dynamics in response to visual, auditory, or olfactory stimuli can be imaged in restrained animals, while wireless head-mounted microscopes enable biosensor imaging in the brains of freely moving animals.
Recently developed fluorescent biosensors for glutamate, dopamine, acetylcholine, adrenaline and GABA allow to detect neuronal activity in vivo with high spatiotemporal precision. Single-FP-based intensiometric biosensors represent the most useful group of the biosensors because they are monochromic and have the higher dynamic range than FRET-based, thus, enabling spectral multiplexing with other biosensors or optogenetic tools and imaging of neuronal activity in vivo, respectively.
|
FRET-based biosensors |
FRET pair | Relative change of FRET ratio,ΔR/R (%) | Kd (μM) | Conditions used to measure ΔR/R and Kd | Substance (neurotransmitter or neuromodulator) | Template for sensing domain | In vivo use | References |
| SuperGluSnFR | ECFP-Citrine | 44 | 2.5 | Cultured neurons, 1P microscopy | Glutamate | GltI | Not tested | Hires et al., 2008 |
| M1-cam5 | ECFP-EYFP | 10 | Not determined | HEK293 cells, 1P microscopy | Acetylcholine | M1mAChR | Markovic et al., 2012 | |
| GlyFS | EGFP-Venus | 20 | 20 | Brain slices, 2P microscopy | Glycine | Atu2422 (AYW mutant) | Zhang et al., 2018 | |
| Single-FP-based biosensors | Circularly permuted FP | Relative change of fluorescence,ΔF/F (%) | Kd (μM) | Conditions used to measure ΔF/F and Kd | Substance (neurotransmitter or neuromodulator) | Template for sensing domain | In vivo use | References |
| iGluSnFR | cpGFP | 103 | 4.9 | Cultured neurons, 1P microscopy | Glutamate | GltI | Imaging of dendritic spines | Marvin et al., 2013 |
| SF-iGluSnFR A184V | sfGFP | 69 | 0.6 | Marvin et al., 2018 | ||||
| SF-iGluSnFR S72A | 250 | 34 | ||||||
| SF-Azurite-iGluSnFR | Azurite | 66 | 46 | |||||
| SF-Venus-iGluSnFR | Venus | 66 | 2 | |||||
| SF-mTurquoise2-iGluSnFR | mTurquoise | 90 | 41 | |||||
| iGABASnFR | sfGFP | 250 | 9 | Purified protein, fluorimeter | GABA | Pf622 | Imaging of single neurons | Marvin et al., 2019 |
| iGluf | EGFP | 100 | 137 | HEK293 cells, stopped-flow | Glutamate | GltI | Not tested | Helassa et al., 2018 |
| iGluu | 170 | 600 | ||||||
| R-iGluSnFR1 | mApple | −33 | 11 | Purified protein, fluorimeter | Wu et al., 2018 | |||
| R-ncp-iGluSnFR1 | 0.9 | |||||||
| GACh | EGFP | 90 | 2 | HEK293 cells, 1P microscopy | Acetylcholine | M3R | Imaging of single neurons | Jing et al., 2018 |
| GRABNE1m | 230 | 1.9 | Norepinephrine | α2AR | Aggregated fluorescence signal | Feng et al., 2019 | ||
| GRABNE1h | 150 | 0.093 | ||||||
| Nb80-GFP | Not determined | Not determined | Not applicable | β2AR/Nb80 | Not tested | Irannejad et al., 2013 | ||
| OR-sensor | EGFP | Not determined | Not determined | Not applicable | Activation of μ and δ ORs | μ and δ ORs/Nb33 | Not tested | Stoeber et al., 2018 |
| iATPSnFR | spGFP | 150 | 630 | Cultured neurons, 1P microscopy | ATP | ε subunit of FOF1 ATPase from Bacillus PS3 | Imaging of single astrocytes | Lobas et al., 2018 |
| dLight1.1 | EGFP | 230 | 0.33 | HEK293 cells, 1P microscopy | Dopamine | DRD1 (inserted into the ICL3) | Aggregated fluorescence signal | Patriarchi et al., 2018 |
| dLight1.2 | 340 | 0.77 | ||||||
| DA1m | 90 | 0.13 | DRD2 (inserted into the ICL3) | Sun et al., 2018 | ||||
| DA1h | 0.01 | |||||||
AAV Biosensors
AAV biosensors are genetically encoded reporter systems delivered by AAV vectors that convert intracellular biological events into measurable optical or luminescent signals in living cells, tissues, or animals. They allow non-invasive, cell-type–specific, and longitudinal monitoring of signaling pathways, neuronal activity, and cellular states in vivo—which is why they are becoming a core tool in neuroscience, immunology, and gene-therapy development.
In practice, an AAV biosensor is built from four components:
a promoter (to define which cells are measured), a sensor module (that detects a biochemical activity), a reporter (fluorescent or luminescent), and an AAV capsid (that determines which tissues are transduced). AAV makes biosensors usable in vivo, not just in cultured cells:
-
Stable, long-term expression (months to years)
-
Cell-type specificity using promoters (Syn, GFAP, CamKII, CD4, etc.)
-
Deep tissue access using engineered capsids (BBB, retina, muscle, lung)
-
Repeated measurements in the same animal
